Erratum to “Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes” [Int. Immunopharmacol. 19 (2014) 206–213] (International Immunopharmacology (2014) 19(2) (206–213), (S1567576914000460), (10.1016/j.intimp.2014.02.002));Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes

International Immunopharmacology

Volumn 19, Issue 2, 2014, Pages 206-213

  Wang, Dong Tao ^a   Yin, Yi ^a   Yang, Ya Jun ^a   Lv, Pei Jia ^a   Shi, Ying ^a   Lu, Lu ^a   Wei, Lian Bo ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Muscle atrophy; Resveratrol; TNF

Indexed keywords

ATROGIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MUSCLE PROTEIN; MUSCLE RING FINGER 1 PROTEIN; PROTEIN KINASE B; RESVERATROL; TRANSCRIPTION FACTOR FKHR; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; IN VITRO STUDY; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE HYPERTROPHY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUPPLEMENTATION;

MUSCLE ATROPHY; RESVERATROL; TNF-Α;

ANIMALS; CELL LINE; FORKHEAD TRANSCRIPTION FACTORS; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCULAR ATROPHY; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; STILBENES; TOR SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES;

EID: 84896714782     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2022.108776     Document Type: Erratum

References (53)

1. S.H. Lecker, R.T. Jagoe, A. Gilbert, M. Gomes, V. Baracos, and J. Bailey et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression FASEB J 18 2004 39 51 (Pubitemid 38076464)
2. S. Acharyya, K.J. Ladner, L.L. Nelsen, J. Damrauer, P.J. Reiser, and S. Swoap et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products J Clin Invest 114 2004 370 378 (Pubitemid 39071609)
3. A. Doyle, G. Zhang, E.A.A. Fattah, N.T. Eissa, and Y.-P. Li Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways FASEB J 25 2011 99 110
4. G. Strassmann, M. Fong, J. Kenney, and C. Jacob Evidence for the involvement of interleukin 6 in experimental cancer cachexia J Clin Invest 89 1992 1681
5. O. Zamir, W. O'Brien, R. Thompson, D.C. Bloedow, J.E. Fischer, and P.-O. Hasselgren Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist Int J Biochem 26 1994 943 950
6. R.C. Langen, A.M. Schols, M.C. Kelders, J.L. van der Velden, E.F. Wouters, and Y.M. Janssen-Heininger Tumor necrosis factor-α inhibits myogenesis through redox-dependent and-independent pathways Am J Physiol-Cell Physiol 283 2002 C714 C721
7. D.J. Glass Molecular mechanisms modulating muscle mass Trends Mol Med 9 2003 344 350 (Pubitemid 37040030)
8. M.D. Gomes, S.H. Lecker, R.T. Jagoe, A. Navon, and A.L. Goldberg Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy Proc Natl Acad Sci 98 2001 14440 14445 (Pubitemid 33121410)
9. R.T. Jagoe, S.H. Lecker, M. Gomes, and A.L. Goldberg Patterns of gene expression in atrophying skeletal muscles: response to food deprivation FASEB J 16 2002 1697 1712 (Pubitemid 35345118)
10. Palma Ld, M. Marinelli, M. Pavan, and A. Orazi Ubiquitin ligases MuRF1 and MAFbx in human skeletal muscle atrophy Joint Bone Spine 75 2008 53 57
11. D.J. Glass Skeletal muscle hypertrophy and atrophy signaling pathways Int J Biochem Cell Biol 37 2005 1974 1984 (Pubitemid 41206815)
12. S. Wullschleger, R. Loewith, and M.N. Hall TOR signaling in growth and metabolism Cell 124 2006 471 484 (Pubitemid 43199434)
13. S.C. Bodine, T.N. Stitt, M. Gonzalez, W.O. Kline, G.L. Stover, and R. Bauerlein et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo Nat Cell Biol 3 2001 1014 1019 (Pubitemid 34428747)
14. N. Hay, and N. Sonenberg Upstream and downstream of mTOR Genes Dev 18 2004 1926 1945 (Pubitemid 39071573)
15. C.F. Bentzinger, K. Romanino, D. Cloëtta, S. Lin, J.B. Mascarenhas, and F. Oliveri et al. Skeletal muscle-specific ablation of raptor but not of rictor causes metabolic changes and results in muscle dystrophy Cell Metab 8 2008 411 424
16. S.J. Lee Regulation of muscle mass by myostatin Annu Rev Cell Dev Biol 20 2004 61 86
17. M. Sandri, C. Sandri, A. Gilbert, C. Skurk, E. Calabria, and A. Picard et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy Cell 117 2004 399 412 (Pubitemid 38534545)
18. T.N. Stitt, D. Drujan, B.A. Clarke, F. Panaro, Y. Timofeyva, and W.O. Kline et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors Mol Cell 14 2004 395 403 (Pubitemid 38591410)
19. H. Tran, A. Brunet, E.C. Griffith, and M.E. Greenberg The many forks in FOXO's road Sci Signal 2003 2003 1 11
20. B.J. Sishi, and A.M. Engelbrecht Tumor necrosis factor alpha (TNF-αlpha) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes Cytokine 54 2011 173 184
21. M. Sandri Signaling in muscle atrophy and hypertrophy Physiology (Bethesda) 23 2008 160 170
22. G.J. Soleas, E.P. Diamandis, and D.M. Goldberg The world of resveratrol Adv Exp Med Biol 492 2001 159 182 (Pubitemid 32682074)
23. J. Burns, T. Yokota, H. Ashihara, M.E. Lean, and A. Crozier Plant foods and herbal sources of resveratrol J Agric Food Chem 50 2002 3337 3340 (Pubitemid 34533643)
24. A.J. Dirks Naylor Cellular effects of resveratrol in skeletal muscle Life Sci 84 2009 637 640
25. A. Brunet, A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, and L.S. Hu et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96 1999 857 868 (Pubitemid 29165088)
26. S.T. Russell, S.M. Wyke, and M.J. Tisdale Mechanism of induction of muscle protein degradation by angiotensin II Cell Signal 18 2006 1087 1096
27. S. Wyke, and M. Tisdale Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway Life Sci 78 2006 2898 2910
28. N. Alamdari, Z. Aversa, E. Castillero, A. Gurav, V. Petkova, and S. Tizio et al. Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism Biochem Biophys Res Commun 417 2012 528 533
29. I. Momken, L. Stevens, A. Bergouignan, D. Desplanches, F. Rudwill, and I. Chery et al. Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat FASEB J 25 2011 3646 3660
30. Y.S. Hori, A. Kuno, R. Hosoda, M. Tanno, T. Miura, and K. Shimamoto et al. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy J Pharmacol Exp Ther 338 2011 784 794
31. S. Shadfar, M.E. Couch, K.A. McKinney, L.J. Weinstein, X. Yin, and J.E. Rodriguez et al. Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo Nutr Cancer 63 2011 749 762
32. R. Amat, G. Solanes, M. Giralt, and F. Villarroya SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription J Biol Chem 282 2007 34066 34076 (Pubitemid 350159429)
33. P. Magee, S. Pearson, J. Whittingham-Dowd, and J. Allen PPARγ as a molecular target of EPA anti-inflammatory activity during TNF-α-impaired skeletal muscle cell differentiation J Nutr Biochem 23 2012 1440 1448
34. M. Menconi, P. Gonnella, V. Petkova, S. Lecker, and P.O. Hasselgren Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes J Cell Biochem 105 2008 353 364
35. M.N. Goodman Tumor necrosis factor induces skeletal muscle protein breakdown in rats Am J Physiol 260 1991 E727 E730
36. Y.P. Li, Y. Chen, J. John, J. Moylan, B. Jin, and D.L. Mann et al. TNF-αlpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle FASEB J 19 2005 362 370 (Pubitemid 40316524)
37. C. Rommel, S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, and T.N. Stitt et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways Nat Cell Biol 3 2001 1009 1013 (Pubitemid 34428746)
38. S.-Y. Lin, W.-Y. Chen, F.-Y. Lee, C.-J. Huang, and W.H.-H. Sheu Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-α Am J Physiol-Endocrinol Metab 288 2005 E493 E501
39. M. Llovera, N. Carbo, J. Lopez-Soriano, C. Garcia-Martinez, S. Busquets, and B. Alvarez et al. Different cytokines modulate ubiquitin gene expression in rat skeletal muscle Cancer Lett 133 1998 83 87 (Pubitemid 29069115)
40. M. Llovera, C. García-Martínez, N. Agell, F.J. López-Soriano, and J.M. Argilés TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles Biochem Biophys Res Commun 230 1997 238 241 (Pubitemid 27211974)
41. M. Llovera, F.J. López-Soriano, and J.M. Argilés Effects of tumor necrosis factor-α on muscle-protein turnover in female Wistar rats J Natl Cancer Inst 85 1993 1334 1339 (Pubitemid 23249726)
42. J.P. White, S. Gao, M.J. Puppa, S. Sato, S.L. Welle, and J.A. Carson Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle Mol Cell Endocrinol 365 2013 174 186
43. Reynolds THt, S.C. Bodine, and J.C. Lawrence Jr. Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load J Biol Chem 277 2002 17657 17662 (Pubitemid 34967569)
44. X.-d. Peng, P.-Z. Xu, M.-L. Chen, A. Hahn-Windgassen, J. Skeen, and J. Jacobs et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2 Genes Dev 17 2003 1352 1365 (Pubitemid 36666005)
45. R. Mounier, L. Lantier, J. Leclerc, A. Sotiropoulos, M. Foretz, and B. Viollet Antagonistic control of muscle cell size by AMPK and mTORC1 Cell Cycle 10 2011 2640 2646
46. S.W. Lee, G. Dai, Z. Hu, X. Wang, J. Du, and W.E. Mitch Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase J Am Soc Nephrol 15 2004 1537 1545 (Pubitemid 38679678)
47. P.G. Giresi, E.J. Stevenson, J. Theilhaber, A. Koncarevic, J. Parkington, and R.A. Fielding et al. Identification of a molecular signature of sarcopenia Physiol Genomics 21 2005 253 263 (Pubitemid 40898485)
48. Y.H. Song, Y. Li, J. Du, W.E. Mitch, N. Rosenthal, and P. Delafontaine Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting J Clin Invest 115 2005 451 458 (Pubitemid 40385487)
49. Y. Kamei, S. Miura, M. Suzuki, Y. Kai, J. Mizukami, and T. Taniguchi et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control J Biol Chem 279 2004 41114 41123 (Pubitemid 39287713)
50. J.S. Moylan, J.D. Smith, M.A. Chambers, T.J. McLoughlin, and M.B. Reid TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling Am J Physiol-Cell Physiol 295 2008 C986 C993
51. S. Busquets, G. Fuster, E. Ametller, M. Olivan, M. Figueras, and P. Costelli et al. Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models Clin Nutr 26 2007 239 244 (Pubitemid 46477830)
52. S. Wyke, S. Russell, and M. Tisdale Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-κB activation Br J Cancer 91 2004 1742 1750 (Pubitemid 39546149)
53. C.-J. Chen, W. Yu, Y.-C. Fu, X. Wang, J.-L. Li, and W. Wang Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway Biochem Biophys Res Commun 378 2009 389 393